These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23389975)

  • 21. Multidrug-resistant E. coli and enterobacter extraintestinal infection in 37 dogs.
    Gibson JS; Morton JM; Cobbold RN; Sidjabat HE; Filippich LJ; Trott DJ
    J Vet Intern Med; 2008; 22(4):844-50. PubMed ID: 18647154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Strain of Escherichia coli resistant to broad-spectrum cephalosporin and amoxicillin/clavulanic acid].
    Martín-Pozo A; Alós JI
    Rev Esp Quimioter; 2012 Sep; 25(3):222-3. PubMed ID: 22987271
    [No Abstract]   [Full Text] [Related]  

  • 23. Retail meat consumption and the acquisition of antimicrobial resistant Escherichia coli causing urinary tract infections: a case-control study.
    Manges AR; Smith SP; Lau BJ; Nuval CJ; Eisenberg JN; Dietrich PS; Riley LW
    Foodborne Pathog Dis; 2007; 4(4):419-31. PubMed ID: 18041952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility pattern of bacteria isolated from patients with urinary tract infection.
    Khan IU; Mirza IA; Ikram A; Afzal A; Ali S; Hussain A; Fayyaz M; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Nov; 24(11):840-4. PubMed ID: 25404444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of adherence of multi-drug resistant E. coli by proanthocyanidin.
    Gupta A; Dwivedi M; Mahdi AA; Nagana Gowda GA; Khetrapal CL; Bhandari M
    Urol Res; 2012 Apr; 40(2):143-50. PubMed ID: 21688109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility patterns among Escherichia coli urinary isolates from community-onset health care-associated urinary tract infection.
    Huang LF; Lo YC; Su LH; Chang CL
    J Formos Med Assoc; 2014 Dec; 113(12):970-3. PubMed ID: 24548621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli.
    Rippere-Lampe KE; O'Brien AD; Conran R; Lockman HA
    Infect Immun; 2001 Jun; 69(6):3954-64. PubMed ID: 11349064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae.
    So W; Crandon JL; Nicolau DP
    J Urol; 2015 Aug; 194(2):563-70. PubMed ID: 25637857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virulence Genes and Antibiotic Susceptibilities of Uropathogenic E. coli Strains.
    Uzun C; Oncül O; Gümüş D; Alan S; Dayioğlu N; Küçüker MA
    Clin Lab; 2015; 61(8):941-50. PubMed ID: 26427137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking adherence of uropathogenic Escherichia coli isolate to HEP-2 cells and bladder of mice in the presence of antibody against p-fimbriae.
    Bidhendi SM; Sattari M; Pourbakhsh SA; Mobarez A; Vandyousefi J; Khaki P; Heidari MH; Kazemnejad A
    Biologicals; 2007 Apr; 35(2):99-105. PubMed ID: 16879977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections.
    Can F; Azap OK; Seref C; Ispir P; Arslan H; Ergonul O
    Clin Infect Dis; 2015 Feb; 60(4):523-7. PubMed ID: 25378460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008).
    Matsumoto T; Hamasuna R; Ishikawa K; Takahashi S; Yasuda M; Hayami H; Tanaka K; Kiyota H; Muratani T; Monden K; Arakawa S; Yamamoto S
    Int J Antimicrob Agents; 2011 Mar; 37(3):210-8. PubMed ID: 21242062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children.
    Allen UD; MacDonald N; Fuite L; Chan F; Stephens D
    CMAJ; 1999 May; 160(10):1436-40. PubMed ID: 10352632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of mastoparan-AF alone and in combination with clinically used antibiotics against multiple-antibiotic-resistant Escherichia coli isolates from animals.
    Lin CH; Hou RF; Shyu CL; Shia WY; Lin CF; Tu WC
    Peptides; 2012 Jul; 36(1):114-20. PubMed ID: 22561066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.
    Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn RJ; McDermott T; Murphy P; Grainger R; Fennell JP; Thornhill JA
    BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells.
    Bishop BL; Duncan MJ; Song J; Li G; Zaas D; Abraham SN
    Nat Med; 2007 May; 13(5):625-30. PubMed ID: 17417648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.
    Bin C; Hui W; Renyuan Z; Yongzhong N; Xiuli X; Yingchun X; Yuanjue Z; Minjun C
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):351-7. PubMed ID: 16934430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amaranthus caudatus extract inhibits the invasion of E. coli into uroepithelial cells.
    Mohanty S; Zambrana S; Dieulouard S; Kamolvit W; Nilsén V; Gonzales E; Östenson CG; Brauner A
    J Ethnopharmacol; 2018 Jun; 220():155-158. PubMed ID: 29621584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of a Stewardship-Initiated Restriction on Empirical Use of Ciprofloxacin on Nonsusceptibility of Escherichia coli Urinary Isolates to Ciprofloxacin.
    O'Brien KA; Zhang J; Mauldin PD; Gomez J; Hurst JM; Sean Boger M; Bosso JA
    Pharmacotherapy; 2015 May; 35(5):464-9. PubMed ID: 26011139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.